"Survival Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
| Descriptor ID |
D015996
|
| MeSH Number(s) |
E05.318.308.985.550.900 N01.224.935.698.826 N06.850.505.400.975.550.900 N06.850.520.308.985.550.900
|
| Concept/Terms |
Survival Rate- Survival Rate
- Rate, Survival
- Rates, Survival
- Survival Rates
Mean Survival Time- Mean Survival Time
- Mean Survival Times
- Survival Time, Mean
- Survival Times, Mean
- Time, Mean Survival
- Times, Mean Survival
Cumulative Survival Rate- Cumulative Survival Rate
- Cumulative Survival Rates
- Rate, Cumulative Survival
- Rates, Cumulative Survival
- Survival Rate, Cumulative
- Survival Rates, Cumulative
|
Below are MeSH descriptors whose meaning is more general than "Survival Rate".
Below are MeSH descriptors whose meaning is more specific than "Survival Rate".
This graph shows the total number of publications written about "Survival Rate" by people in this website by year, and whether "Survival Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 62 | 62 |
| 1995 | 0 | 85 | 85 |
| 1996 | 0 | 88 | 88 |
| 1997 | 0 | 56 | 56 |
| 1998 | 0 | 80 | 80 |
| 1999 | 0 | 101 | 101 |
| 2000 | 0 | 84 | 84 |
| 2001 | 0 | 122 | 122 |
| 2002 | 0 | 130 | 130 |
| 2003 | 1 | 130 | 131 |
| 2004 | 0 | 110 | 110 |
| 2005 | 0 | 155 | 155 |
| 2006 | 0 | 171 | 171 |
| 2007 | 0 | 182 | 182 |
| 2008 | 0 | 175 | 175 |
| 2009 | 0 | 174 | 174 |
| 2010 | 1 | 213 | 214 |
| 2011 | 1 | 244 | 245 |
| 2012 | 2 | 207 | 209 |
| 2013 | 2 | 199 | 201 |
| 2014 | 3 | 197 | 200 |
| 2015 | 0 | 230 | 230 |
| 2016 | 1 | 258 | 259 |
| 2017 | 1 | 301 | 302 |
| 2018 | 2 | 256 | 258 |
| 2019 | 2 | 275 | 277 |
| 2020 | 0 | 220 | 220 |
| 2021 | 0 | 147 | 147 |
| 2022 | 0 | 34 | 34 |
| 2023 | 0 | 27 | 27 |
| 2024 | 0 | 78 | 78 |
To return to the timeline,
click here.
Below are the most recent publications written about "Survival Rate" by people in Profiles.
-
SDHB-Associated Pheochromocytomas: What is Their Clinical Behavior? Ann Surg Oncol. 2024 Dec; 31(13):9007-9013.
-
Sex-Specific Differences in Patients with IDH1-Wild-Type Grade 4 Glioma in the ReSPOND Consortium. AJNR Am J Neuroradiol. 2024 Sep 09; 45(9):1299-1307.
-
Patterns of Care and Outcomes of Patients with Small Gastrointestinal Stromal Tumors at a High-Volume Sarcoma Center. Ann Surg Oncol. 2024 Dec; 31(13):9258-9264.
-
Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer. 2024 Nov; 71(11):e31303.
-
A Multi-Center International Analysis of Lung Transplantation Outcomes in Patients With COVID-19. Clin Transplant. 2024 Sep; 38(9):e15462.
-
A Phase I Open-Label Study of Cediranib Plus Etoposide and Cisplatin as First-Line Therapy for Patients With Extensive-Stage Small-Cell Lung Cancer or Metastatic Neuroendocrine Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Nov; 25(7):601-611.
-
Follicular Lymphoma in Chile in the Adult Public Cancer Program: The Impact of Chemoimmunotherapy. Cancer Rep (Hoboken). 2024 Sep; 7(9):e2126.
-
Extracorporeal cardiopulmonary resuscitation for pediatric out-of-hospital cardiac arrest: A review of the Extracorporeal Life Support Organization Registry. Resuscitation. 2024 10; 203:110380.
-
A phase 2 trial of mini-hyper-CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia. Am J Hematol. 2024 Nov; 99(11):2229-2232.
-
Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2024 Dec; 31(13):8795-8801.